The ROE as of September 2024 (TTM) for Sirona Biochem Corp. (SRBCF) is 95.24%

According to Sirona Biochem Corp.’s latest financial reports and current stock price. The company's current ROE is 95.24%. This represents a change of 263.90% compared to the average of 26.17% of the last 4 quarters.

Sirona Biochem Corp. (SRBCF) Historical ROE (quarterly & annually)

How has SRBCF ROE performed in the past?

The mean historical ROE of Sirona Biochem Corp. over the last ten years is -837.30%. The current 95.24% ROE has changed -111.37% with respect to the historical average. Over the past ten years (40 quarters), SRBCF's ROE was at its highest in in the July 2017 quarter at 441.85%. The ROE was at its lowest in in the October 2020 quarter at -858.99%.

Sirona Biochem Corp. (SRBCF) ROE by Quarter and Year

Discovering the peaks and valleys of Sirona Biochem Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sirona Biochem Corp. (SRBCF) Average ROE

How has SRBCF ROE performed in the past?

The current ROE of Sirona Biochem Corp. (SRBCF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sirona Biochem Corp. (SRBCF) ROE vs. Peers

How is SRBCF’s ROE compared to its peers?

Sirona Biochem Corp.’s ROE is less than Adynxx, Inc. (0%), greater than NLS Pharmaceutics AG (0%), less than Ascletis Pharma Inc. (185.54%), greater than Surrozen, Inc. (-0.82%), greater than Bolt Biotherapeutics, Inc. (-178.66%), greater than Larimar Therapeutics, Inc. (-61.40%), greater than Keros Therapeutics, Inc. (-37.84%), greater than Kezar Life Sciences, Inc. (-44.73%), greater than Coya Therapeutics, Inc. (-54.50%), greater than Cue Biopharma, Inc. (-35.58%), greater than Lantern Pharma Inc. (-142.93%), greater than Fennec Pharmaceuticals Inc. (-46.39%), greater than Eliem Therapeutics, Inc. (-52.10%), greater than SciSparc Ltd. (-47.03%), greater than OncoSec Medical Incorporated (-87.48%), less than Virax Biolabs Group Limited (484.53%), greater than Hillstream BioPharma, Inc. (-115.10%), greater than ZyVersa Therapeutics, Inc. (-47249.59%), greater than Eiger BioPharmaceuticals, Inc. (-172.51%), greater than Spruce Biosciences, Inc. (-869.84%), greater than Werewolf Therapeutics, Inc. (-59.94%), greater than Unicycive Therapeutics, Inc. (-48.25%), less than Fusion Pharmaceuticals Inc. (294.74%), greater than null (-48.74%),

Build a custom stock screener for Sirona Biochem Corp. (SRBCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sirona Biochem Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sirona Biochem Corp. (SRBCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sirona Biochem Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.